Improving treatment for people with kidney transplants

CAMPATH, Calcineurin inhibitor reduction and Chronic allograft nephropathy trial

PATIENT INFORMATION SHEET

Information about a study you might be asked to join

This detailed information is broken into two parts. A summary of the two parts follows below.

To read part 1, click here.

To read part 2, click here.

Summary of invitation to take part in the 3C Study

• The 3C study aims to test new ways to make kidney transplants last longer
• Kidney transplantation requires drugs to be taken for a long period of time. Some of these drugs can damage the transplant in the long-term or have other harmful side-effects (e.g. diabetes, high blood pressure).
• If shown to be effective, the widespread use of CAMPATH or sirolimus may lengthen the lifespan of many thousands of kidney transplants around the world each year.
• Using sirolimus instead of tacrolimus may mean that drugs that damage the kidney in the long-term can be avoided.
• With your help we can answer this question reliably.

THANK YOU FOR YOUR HELP.